Navigating Big Pharma's Role in Addiction Treatment

The amount of overdose deaths in the U.S. is staggering. And while addiction is a disease, there’s no specific medical treatment or cure for it. Our guest this week points out that weight loss drugs and GLP-1s, or glucagon-like peptide-1s, which are used to treat type 2 diabetes and obesity, can be effective for helping people reduce cravings and consumption of drugs, alcohol and compulsive behaviors like gambling. Nick Reville is the cofounder and executive director of the Center for Addiction Science, Policy, and Research (CASPR). He joins WITHpod to discuss how he found his way into this research area, lessons learned from other health crises, innovations geared towards eliminating addictions at a widescale level and more.